Search research articles
Contact Us
Filters
Showing results (141-150 of 293) with videos related to
Page
of 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2014
Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice
Owen A O'Connor, Govind Bhagat, Karthik Ganapathi, et al.
Seminars in Cancer Biology
|
May 13, 2025
HDAC inhibitors: Cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injury
Kenneth K W To, Seda S Tolu, Longling Wang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 14, 2012
Drug resistance: still a daunting challenge to the successful treatment of AML
Brian C Shaffer, Jean-Pierre Gillet, Chirayu Patel, et al.
Molecular Pharmaceutics
|
September 9, 2011
Histone deacetylase inhibitors: emerging mechanisms of resistance
Robert W Robey, Arup R Chakraborty, Agnes Basseville, et al.
Cell Reports
|
February 12, 2013
Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma
Krastan B Blagoev, Julia Wilkerson, Wilfred D Stein, et al.
The Oncologist
|
January 13, 2021
A Medical Pearl Harbor: Pandemic Uncovers Societal Fissures and Leadership Breaches
Bruce A Chabner, Susan E Bates, Antonio Tito Fojo, et al.
Cancer Biology & Therapy
|
March 19, 2003
Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1)
Yasumasa Honjo, Kuniaki Morisaki, Lyn Mickley Huff, et al.
The Oncologist
|
June 17, 2024
Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors
Jacob K Jamison, Mengxi Zhou, Edward P Gelmann, et al.
Clinical Lymphoma & Myeloma
|
September 4, 2008
Cardiac involvement with lymphoma: a review of the literature
Deirdre O'Mahony, Richard L Peikarz, W Patricia Bandettini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2018
Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (<i>SLFN11)</i> Expression with Class I Histone Deacetylase Inhibitors
Sai-Wen Tang, Anish Thomas, Junko Murai, et al.
Page
of 30
Search research articles
Search
Showing results (141-150 of 293) with videos related to
Sort By:
Page
of 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2014
Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice
Owen A O'Connor, Govind Bhagat, Karthik Ganapathi, et al.
Seminars in Cancer Biology
|
May 13, 2025
HDAC inhibitors: Cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injury
Kenneth K W To, Seda S Tolu, Longling Wang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 14, 2012
Drug resistance: still a daunting challenge to the successful treatment of AML
Brian C Shaffer, Jean-Pierre Gillet, Chirayu Patel, et al.
Molecular Pharmaceutics
|
September 9, 2011
Histone deacetylase inhibitors: emerging mechanisms of resistance
Robert W Robey, Arup R Chakraborty, Agnes Basseville, et al.
Cell Reports
|
February 12, 2013
Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma
Krastan B Blagoev, Julia Wilkerson, Wilfred D Stein, et al.
The Oncologist
|
January 13, 2021
A Medical Pearl Harbor: Pandemic Uncovers Societal Fissures and Leadership Breaches
Bruce A Chabner, Susan E Bates, Antonio Tito Fojo, et al.
Cancer Biology & Therapy
|
March 19, 2003
Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1)
Yasumasa Honjo, Kuniaki Morisaki, Lyn Mickley Huff, et al.
The Oncologist
|
June 17, 2024
Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors
Jacob K Jamison, Mengxi Zhou, Edward P Gelmann, et al.
Clinical Lymphoma & Myeloma
|
September 4, 2008
Cardiac involvement with lymphoma: a review of the literature
Deirdre O'Mahony, Richard L Peikarz, W Patricia Bandettini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2018
Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (<i>SLFN11)</i> Expression with Class I Histone Deacetylase Inhibitors
Sai-Wen Tang, Anish Thomas, Junko Murai, et al.
Page
of 30